ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1529 • 2015 ACR/ARHP Annual Meeting

    Trabecular Bone Score in Early Rheumatoid Arthritis

    Eulalia Armengol1, Helena Borrell Paños1, Joan Miquel Nolla1, Javier Narváez2 and Carmen Gomez Vaquero1, 1Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with low bone mass and increased risk of fragility fractures that are related to patient characteristics, treatments and disease…
  • Abstract Number: 1530 • 2015 ACR/ARHP Annual Meeting

    Neutrophil Function and Survival Unaffected in Healthy Subjects Following Single Administration of Tocilizumab

    Laurence Lok1, Jatinder Juss1, Neda Farahi1, Chrystalla Loutsios1, Chandra Solanki2, Adrien Michael Peters3, Sophie Dimonaco4, Francis Donaldson4, Benjamin Porter-Brown4 and Edwin Chilvers1, 1Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 2Department of Nuclear Medicine, Cambridge University Hospitals, Cambridge, United Kingdom, 3Division of Clinical and Laboratory Investigation, Brighton and Sussex Medical School, Brighton, United Kingdom, 4Roche Products Ltd., Welwyn Garden City, United Kingdom

    Background/Purpose: Decreases in circulating neutrophil counts have been observed in adults with rheumatoid arthritis (RA) and children with systemic or polyarticular juvenile idiopathic arthritis treated…
  • Abstract Number: 1531 • 2015 ACR/ARHP Annual Meeting

    The Changing Face of Septic Arthritis Complicating Rheumatoid Arthritis in the Era of Biotherapies. Retrospective Single-Center Study over 35 Years

    Jean-Jacques Dubost1, Bruno Pereira2, Anne Tournadre3, Zuzana Tatar1, Marion Couderc1 and Martin Soubrier1, 1Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, 2Biostatistics unit (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France, 3Rheumatology, UNH-UMR 1019 INRA University of Auvergne and Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France

    Background/Purpose: Rheumatoid arthritis (RA) is a risk factor for septic arthritis (SA), and anti-TNF therapy doubles the risk of SA. The purpose of this study…
  • Abstract Number: 1532 • 2015 ACR/ARHP Annual Meeting

    Occurrence of Valvular Heart Disease in Rheumatoid Arthritis: A Population Based Study

    Tamanna Khullar1, John P. Bois1, Cynthia S. Crowson2, Megan L. Krause3 and Rekha Mankad1, 1Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis (RA) are known to have an increased risk of cardiovascular disease, particularly atherosclerosis and heart failure.  However, little is known…
  • Abstract Number: 1533 • 2015 ACR/ARHP Annual Meeting

    Age Related Disability in Daily Life Should be Considered in Older Than Sixty-Five-Year-Old Rheumatoid Arthritis Patient

    Ichiro Yoshii1 and Tatsumi Chijiwa2, 1Department of Orthopaedic Surgery, Yoshii Hospital, Shimanto, Japan, 2Rheumatology, Kochi Memorial Hospital, Kochi, Japan

    Background/Purpose:  In treating rheumatoid arthritis (RA), patient’s activity in daily life (ADL) is extremely important factor, because RA is chronic inflammatory disease that leads discomfort…
  • Abstract Number: 1534 • 2015 ACR/ARHP Annual Meeting

    Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations

    Narender Annapureddy1, Achint Patel2, Rabi Yacoub3, Krishna Pakanati4, Shiv Agarwal5, Priya Simoes6, Shaan Patel3, Sunil Kamat7, Alexandre Benjo8 and Girish Nadkarni9, 1Rheumatology and Immunology, Vanderbilt University, Nashville, TN, 2Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, 3Icahn School of Medicine at Mount Sinai, New York, NY, 4Gateway Medical Center, Clarksville, TN, 5Cardiology, University of Arkansas Medical Sciences, Little Rock, AR, 6Internal Medicine, St.Lukes Roosevelt Hospital Center at Mount Sinai, New York, NY, 7Critical Care, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India, 8Ochsner Clinic Foundation, New Orleans, NY, 9Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased risk of cardiac mortality. With better treatment modalities, some studies suggest that infarction (AMI) mortality in RA…
  • Abstract Number: 1535 • 2015 ACR/ARHP Annual Meeting

    The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study

    Kichul Shin1, Eun Young Ahn2, Hyun Mi Kwon2, In Ah Choi3, Yeonsoo Baik4 and Yeong Wook Song2, 1Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 3Division of Rheumatology, Department of internal medicine, Chungbook National University Hospital, Cheongju-si, South Korea, 4Division of Rheumatology, Department of internal medicine, SMG-SNU Boramae Medical Center, Seoul, South Korea

    Background/Purpose: Obesity has recently been spotlighted as an important comorbidity in rheumatoid arthritis (RA); not only associated with disease severity but also its development. Despite…
  • Abstract Number: 1536 • 2015 ACR/ARHP Annual Meeting

    Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients without Traditional Cardiovascular Risk Factors

    Hector Macias Reyes1, Sergio Duran-Barragan2,3, Cynthia Cardenas Contreras4, Cesar Chavez Martin4, Eduardo Gomez2, Rosa Navarro Hernandez2, Jorge Aguilar Arreola2,5, Paul Perez-Cruz2,5, Carlos Yanowsky Gonzalez2 and Monica Vazquez-Del Mercado2,5, 11. Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, 2Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Instituto de Investigación en Reumatología y del Sistema Musculoesquelético, Guadalajara, Mexico, 3Clinica de Investigación en Reumatología y Obesidad, Guadalajara, Mexico, 4Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, 5Servicio de Reumatología, División de Medicina Interna, Hospital Civil Dr. Juan I. Menchaca, Guadalajara, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by inflammation of the synovial membrane of the diarthrodial joints which include arthrodesis of the middle ear, (incudomalleolar and…
  • Abstract Number: 1537 • 2015 ACR/ARHP Annual Meeting

    Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis

    sarah marouen1, Thomas Barnetche2, Bernard Combe3, Jacques Morel4 and Claire I. Daien4, 1Rhumatology Department, Lapeyronie Hospital and Montpellier University, Montpellier, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Rheumatology, Hopital Lapeyronie, Montpellier, France, 4Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France

    Background/Purpose: Patients with chronic inflammatory rheumatic disease have elevated circulating concentrations of TNF-alpha and other pro-inflammatory cytokines that can modify body composition. Metabolic changes are…
  • Abstract Number: 1538 • 2015 ACR/ARHP Annual Meeting

    Clinical Analysis of 30 Rheumatoid Arthritis Patients Complicated with Malignant Lymphoma, Especially Methotrexate-Related Lymphoproliferative Disorder

    Takuma Tsuzuki Wada1, Yuji Akiyama1 and Toshihide Mimura2, 1Department of Rheumatology & Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma, Japan, 2Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

    Background/Purpose: Recently, methotrexate (MTX) has been considered as the anchor drug in the treatment of rheumatoid arthritis (RA). However, it has been reported that MTX…
  • Abstract Number: 1539 • 2015 ACR/ARHP Annual Meeting

    Control of Modifiable Cardiovascular Risk Factors in Rheumatoid Arthritis Patients Compared to Traditional High-Risk Cardiovascular Disease Patients

    Brian LaMoreaux1, Alexa Meara2 and Wael N. Jarjour3, 1Rheumatology, The Ohio State University, Columbus, OH, 2Internal Medicine/Rheumatology, The Ohio State University, Columbus, OH, 3Department of Internal Medicine, Division of Immunology and Rheumatology, The Ohio State University Medical Center, Columbus, OH

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease affecting one percent of the population.  The main cause of mortality among RA patients…
  • Abstract Number: 1540 • 2015 ACR/ARHP Annual Meeting

    Cardiovascular Risk Management in Rheumatoid Arthritis Patients

    Calin Popa1, Elke.E.A. Arts1, Inger L. Meek1, Frank H.J. van den Hoogen2 and Jaap Fransen1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients have been previously shown to have a higher cardiovascular (CV) burden as compared to the general population. The CV risk…
  • Abstract Number: 1541 • 2015 ACR/ARHP Annual Meeting

    Subgroups of Established Rheumatoid Arthritis Patients Can be Characterized By Patient and Physician Assessment Discrepancy, Anxiety and Depression and Presence of Depression Might be Associated with Slower Response to Treatment

    Yong Gil Hwang1, Juan (June) Feng2, Heather Eng2, Jason Lyons2, Anthony Fabio3 and Larry W. Moreland4, 1Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 3Department Of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 4Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Rheumatoid arthritis (RA) is a heterogeneous inflammatory disease with various signs and symptoms.  Previous studies have shown that RA patients can be sub-grouped based…
  • Abstract Number: 1542 • 2015 ACR/ARHP Annual Meeting

    Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis

    Ariana González-Meléndez1, Ruth Fred-Jimenez2, Mariangelí Arroyo-Ávila2, Leyda Díaz-Correa2, Naydi Pérez-Ríos3, Noelia Rodríguez-Pérez2, Grissel Ríos2 and Luis M. Vilá2, 1School of Medicine, Ponce Health Sciences University, Ponce, PR, 2Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 3Puerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, PR

    Background/Purpose: Arterial vascular events have a great impact in the morbidity and mortality of rheumatoid arthritis (RA). Traditional and nontraditional risk factors for arterial vascular…
  • Abstract Number: 1543 • 2015 ACR/ARHP Annual Meeting

    Traditional Risk Score Underestimates the Cardiovascular Risk in Rheumatoid Arthritis Patients

    Tomas Cazenave1, Natalia Zamora1, Gustavo Citera1,2 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina

    Background/Purpose: An increased incidence of cardiovascular (CV) mortality has been reported in patients with rheumatoid arthritis (RA). Adequate stratification of the CV risk is an…
  • « Previous Page
  • 1
  • …
  • 1789
  • 1790
  • 1791
  • 1792
  • 1793
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology